BR0108846A - Formulação de oxazolidinona em comprimido - Google Patents

Formulação de oxazolidinona em comprimido

Info

Publication number
BR0108846A
BR0108846A BR0108846-7A BR0108846A BR0108846A BR 0108846 A BR0108846 A BR 0108846A BR 0108846 A BR0108846 A BR 0108846A BR 0108846 A BR0108846 A BR 0108846A
Authority
BR
Brazil
Prior art keywords
oxazolidinone
tablet formulation
tablet
formulation
provides
Prior art date
Application number
BR0108846-7A
Other languages
English (en)
Inventor
Homer Lin
Ken Yamamoto
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22703542&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0108846(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR0108846A publication Critical patent/BR0108846A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"FORMULAçãO DE OXAZOLIDINONA EM COMPRIMIDO". A presente invenção provê um comprimido prensado de um agente de oxazolidinona antibacteriano que provê carga de medicamento alta e excelente biodisponibilidade.
BR0108846-7A 2000-03-22 2001-03-15 Formulação de oxazolidinona em comprimido BR0108846A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19096900P 2000-03-22 2000-03-22
PCT/US2001/005812 WO2001070225A2 (en) 2000-03-22 2001-03-15 Oxazolidinone tablet formulation

Publications (1)

Publication Number Publication Date
BR0108846A true BR0108846A (pt) 2003-05-06

Family

ID=22703542

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108846-7A BR0108846A (pt) 2000-03-22 2001-03-15 Formulação de oxazolidinona em comprimido

Country Status (33)

Country Link
EP (1) EP1265608B1 (pt)
JP (1) JP2003527424A (pt)
KR (2) KR20070094673A (pt)
CN (1) CN1208058C (pt)
AR (1) AR033357A1 (pt)
AT (1) ATE412413T1 (pt)
AU (2) AU2001243243B2 (pt)
BG (1) BG107117A (pt)
BR (1) BR0108846A (pt)
CA (1) CA2400118A1 (pt)
CZ (1) CZ20023133A3 (pt)
DE (1) DE60136341D1 (pt)
DK (1) DK1265608T3 (pt)
EA (1) EA006772B1 (pt)
EC (1) ECSP013979A (pt)
ES (1) ES2312422T3 (pt)
HK (1) HK1054325B (pt)
HR (1) HRP20020765A2 (pt)
HU (1) HUP0300378A3 (pt)
IL (1) IL151788A0 (pt)
MX (1) MXPA02009316A (pt)
MY (1) MY136370A (pt)
NO (1) NO20024505D0 (pt)
NZ (1) NZ521525A (pt)
PE (2) PE20011126A1 (pt)
PL (1) PL201686B1 (pt)
PT (1) PT1265608E (pt)
SK (1) SK12092002A3 (pt)
TW (1) TWI293028B (pt)
UA (1) UA77654C2 (pt)
WO (1) WO2001070225A2 (pt)
YU (1) YU69802A (pt)
ZA (1) ZA200207073B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
CA2612481A1 (en) * 2005-07-20 2007-02-15 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical composition comprising linezolid form iv
WO2010026597A1 (en) * 2008-09-02 2010-03-11 Hetero Research Foundation Oral dosage forms of linezolid and processes for their preparation
EA027791B1 (ru) 2010-11-24 2017-09-29 Мелинта Терапьютикс, Инк. Фармацевтические композиции
WO2013088389A1 (en) * 2011-12-14 2013-06-20 Alembic Pharmaceuticals Limited Linezolid premix
CN103505459B (zh) * 2012-06-20 2016-02-24 北京万生药业有限责任公司 利奈唑胺药物组合物
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
UA123308C2 (uk) * 2015-04-01 2021-03-17 Екебіа Терапьютікс, Інк. Композиції і способи для лікування анемії
CN106727396A (zh) * 2016-11-22 2017-05-31 湖北广济药业股份有限公司 一种ⅱ晶型利奈唑胺片及其制备方法
CN109481412A (zh) * 2018-08-17 2019-03-19 扬子江药业集团北京海燕药业有限公司 一种ii晶型利奈唑胺片及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993767A (en) * 1975-11-18 1976-11-23 A. H. Robins Company, Incorporated Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
PT1181288E (pt) * 1999-05-27 2003-12-31 Upjohn Co Oxazolidinonas biciclicas como agentes antibacterianos

Also Published As

Publication number Publication date
PT1265608E (pt) 2008-12-15
PE20011126A1 (es) 2001-10-31
HUP0300378A3 (en) 2004-11-29
KR20020083185A (ko) 2002-11-01
HUP0300378A2 (hu) 2003-06-28
NO20024505L (no) 2002-09-20
CZ20023133A3 (cs) 2003-01-15
CA2400118A1 (en) 2001-09-27
HK1054325A1 (en) 2003-11-28
PE20020499Z (es) 2002-07-12
AU4324301A (en) 2001-10-03
WO2001070225A3 (en) 2001-12-13
CN1418097A (zh) 2003-05-14
YU69802A (sh) 2005-11-28
BG107117A (bg) 2003-05-30
PL366067A1 (en) 2005-01-24
WO2001070225A2 (en) 2001-09-27
JP2003527424A (ja) 2003-09-16
AR033357A1 (es) 2003-12-17
HK1054325B (zh) 2006-01-13
ECSP013979A (es) 2002-01-25
EA200201006A1 (ru) 2003-02-27
MXPA02009316A (es) 2004-04-05
DE60136341D1 (de) 2008-12-11
EP1265608A2 (en) 2002-12-18
KR20070094673A (ko) 2007-09-20
PL201686B1 (pl) 2009-04-30
ATE412413T1 (de) 2008-11-15
KR100786410B1 (ko) 2007-12-17
ES2312422T3 (es) 2009-03-01
SK12092002A3 (sk) 2002-12-03
MY136370A (en) 2008-09-30
AU2001243243B2 (en) 2004-10-14
NZ521525A (en) 2004-02-27
CN1208058C (zh) 2005-06-29
NO20024505D0 (no) 2002-09-20
ZA200207073B (en) 2003-12-03
HRP20020765A2 (en) 2003-12-31
UA77654C2 (en) 2007-01-15
EA006772B1 (ru) 2006-04-28
EP1265608B1 (en) 2008-10-29
IL151788A0 (en) 2003-04-10
TWI293028B (en) 2008-02-01
DK1265608T3 (da) 2008-12-08

Similar Documents

Publication Publication Date Title
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
PT1183014E (pt) Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
MY129356A (en) Electrospun pharmaceutical compositions
DE60212847D1 (de) Topisch anwendbare arzneimittelformulierung
BR0111520A (pt) Tiazina oxazolidinona usada como agente antimicrobiano
GEP20032999B (en) 1-Heterocycle Substituted Diarylamines
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
BR0014652A (pt) Fabricação de conjugados de agente terapêutico-poliglutamato
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
FR2653338B1 (fr) Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
PT1113809E (pt) Preparacao farmaceutica contendo um ciclopeptido e um agente quimioterapeutico ou um inibidor de angiogenese
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
BR0108846A (pt) Formulação de oxazolidinona em comprimido
ATE237332T1 (de) Efavirenz enthaltende gepresste tablettenformulierug
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
DK1330258T3 (da) Kahalalid F-formulering
BR0210101A (pt) Combinações antineoplásticas
DE69532809D1 (de) Pharmazeutische präparate, insbesondere ovula, die viele verschiedene aktive bestandteile enthalten
ES2194129T3 (es) Compuestos farmaceuticos.
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
HRPK20030766B3 (en) Combination of a taxane and cyclin-dependent kinase inhibitor
DE59903598D1 (de) Wirkstoffhaltige polyetherblockamide
AR033862A1 (es) Formulacion de medicamento que contiene un agente agonista muscarinico
AU2001258638A1 (en) Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
DK1275383T3 (da) "Modified release" farmaceutisk komposition, der indeholder Bupropion HCI som aktivt stof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A E 11A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.